Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsRent ExpenseShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Acadia Healthcare Company (ACHC) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Acadia Healthcare Company (ACHC) over the last 15 years, with Q3 2025 value amounting to $975.9 million.

  • Acadia Healthcare Company's Accumulated Depreciation & Amortization rose 1283.81% to $975.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $975.9 million, marking a year-over-year increase of 1283.81%. This contributed to the annual value of $896.1 million for FY2024, which is 1677.61% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported Accumulated Depreciation & Amortization of $975.9 million as of Q3 2025, which was up 1283.81% from $980.0 million recorded in Q2 2025.
  • Acadia Healthcare Company's Accumulated Depreciation & Amortization's 5-year high stood at $980.0 million during Q2 2025, with a 5-year trough of $472.5 million in Q1 2021.
  • Its 5-year average for Accumulated Depreciation & Amortization is $718.9 million, with a median of $714.5 million in 2023.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 3879.13% in 2021, then soared by 2192.14% in 2022.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Accumulated Depreciation & Amortization stood at $541.1 million in 2021, then rose by 21.33% to $656.6 million in 2022, then grew by 16.87% to $767.3 million in 2023, then rose by 16.78% to $896.1 million in 2024, then grew by 8.91% to $975.9 million in 2025.
  • Its last three reported values are $975.9 million in Q3 2025, $980.0 million for Q2 2025, and $942.5 million during Q1 2025.